Learn / Conditions / Pelvic, urinary and reproductive
Neuroplastic symptoms · Pelvic, urinary and reproductive

PMDD: when the hormones are normal and the brain's response is not.

Women with PMDD have the same hormone levels as everyone else. What differs is how a sensitized nervous system reacts to them.

Karuna LabsUpdated 2026-10-146 min read
The short answer

Premenstrual dysphoric disorder (PMDD) is a severe form of premenstrual syndrome. In the week or two before a period it brings intense sadness, hopelessness, irritability or anger, along with physical symptoms such as breast tenderness and bloating, and it lifts within a few days of bleeding starting. It can disrupt work and damage relationships. Research shows that women with PMDD do not have abnormal hormone levels; their brains respond differently to normal hormonal change. The ATNS Index of Neuroplastic Symptoms states that issues linked to neuroplastic symptoms, meaning real symptoms produced by learned, sensitized pathways in the brain and nervous system, can be a contributing factor in PMDD and should be assessed. Stress and trauma are recognised amplifiers, and there is an approach that addresses the brain's role alongside medical treatment.

This page is about understanding the condition and the role the brain and nervous system can play in it. It is not a diagnosis. Your own clinicians know your case.

What PMDD is

Most women notice some change in mood or body before a period. Premenstrual dysphoric disorder is at the severe end of that spectrum. In the luteal phase, the week or two after ovulation and before bleeding, symptoms arrive that can feel like a different person taking over: deep sadness, hopelessness, sudden rage, anxiety, feeling overwhelmed, trouble concentrating, and sometimes thoughts of self-harm. Physical symptoms such as breast tenderness, bloating, headaches and joint aches often come too. Within two or three days of the period starting, the fog lifts.

PMDD is diagnosed by tracking symptoms across at least two cycles to confirm that they cluster in the luteal phase and resolve afterward. It is distinct from depression or anxiety that happens all month and simply worsens before a period, although both can coexist. Standard treatments include SSRI antidepressants (which work within days in PMDD, unlike in depression), hormonal contraceptives that suppress ovulation, and lifestyle measures. See our article on premenstrual syndrome for the milder picture.

The neuroplastic contribution

Neuroplastic symptoms are real symptoms produced by learned pathways in the brain and nervous system, a sensitized alarm system, rather than by ongoing damage or disease in the body. They are not imaginary and not 'all in your head', and because the brain can change, they are reversible.

The ATNS Index of Neuroplastic Symptoms states that issues linked to neuroplastic symptoms can be a contributing factor in PMDD and should be assessed. But the modern understanding of PMDD fits the neuroplastic picture unusually well. The hormones are normal. The brain's sensitivity to them is not. And sensitivity is something the nervous system learns and can unlearn.

Several things sharpen that sensitivity:

What the research shows

A review of affective sensitivity to ovarian hormone flux across the menstrual cycle summarises the central finding of PMDD research: women with PMDD cannot be distinguished from women without it by their hormone levels, and the disorder is instead understood as an altered brain response to normal fluctuations. The review discusses biopsychosocial risk factors for that sensitivity, including stress and trauma exposure.

A review of neuroinflammation and stressors in PMS and PMDD describes how the stress axis and the reproductive hormone axis interact to heighten stress sensitivity in the luteal phase, and reports altered cortisol patterns in women with PMDD, including blunted cortisol responses to mental stress. It notes that post-traumatic stress disorder and trauma characteristics are correlates of PMDD and proposes blunted stress-axis activity as one pathway by which early adversity may confer risk, a hypothesis rather than an established mechanism.

A 2025 paper approaches PMDD from a psychosomatic and sensory perspective, examining how heightened sensory and emotional processing in the brain, involving regions such as the amygdala and insula, contributes to the luteal-phase experience. The consistent message is that PMDD is a disorder of brain response, and that stress and trauma tune that response.

Signs the brain may be part of the picture

Try this today

Write a note to your luteal self

On a calm day in the first half of your cycle, take five minutes and write a short letter to the version of you who will exist in ten days. Tell her three things: what is true (your hormones are normal and this is a brain response that will pass), what helps (name two specific things, like a walk or a call to a particular friend), and what to postpone (big decisions, difficult conversations). Keep it on your phone. When the luteal phase arrives, read it. You are giving your sensitized brain accurate information at the moment it is least able to generate it on its own.

A solution that addresses it

Alongside medical treatment, there is an approach that addresses the brain's contribution to PMDD: symptom reprocessing. It combines education about neuroplastic symptoms, somatic tracking (observing the physical and emotional surge with curiosity rather than alarm), reducing the threat attached to the luteal phase, maintaining routines rather than retreating, emotional awareness and expression (the luteal phase often surfaces feelings that are suppressed the rest of the month), and acceptance and commitment skills. Trained clinicians deliver it, and digital programs increasingly make it available at home.

Cindra is a daily AI companion built around these approaches, with daily check-ins that help you see the cycle coming, short practices and plain-language lessons for people whose symptoms have a neuroplastic component. You can join the waitlist.

What to do next

Track your symptoms daily for two cycles and take the record to a clinician, because PMDD is diagnosed by pattern. Ask about treatment options; SSRIs and ovulation-suppressing contraceptives help many women and nothing here suggests avoiding them. If you have thoughts of harming yourself at any point in your cycle, seek help immediately: contact your doctor, a crisis line or emergency services.

Then ask whether a neuroplastic contribution should be assessed, as the index recommends, especially if stress or trauma is part of your history. Start learning how a sensitized brain responds to hormonal shifts, and begin practising in the calm phase so the skills are ready when the luteal phase arrives. Our mindfulness practices and flare plan translate well to a cyclical condition.

Questions people ask

Is PMDD a neuroplastic condition?

The ATNS index says issues linked to neuroplastic symptoms can contribute to PMDD and should be assessed. PMDD is understood as an altered brain response to normal hormone changes, and stress and trauma tune that response, so a neuroplastic contribution is often part of the picture.

Are my hormones abnormal if I have PMDD?

No. Research consistently finds that women with PMDD have the same hormone levels as women without it. The difference lies in how the brain, particularly its serotonin and GABA systems and emotional circuits, reacts to the normal luteal-phase shift.

Can stress or trauma cause PMDD?

They are recognised risk factors and amplifiers. Reviews describe heightened stress sensitivity in the luteal phase and link trauma and PTSD to PMDD, though the exact mechanism is still a hypothesis. Reducing threat and stress reactivity is a reasonable part of treatment.

References

  1. Affective Sensitivity to Ovarian Steroid Hormone Flux Across the Menstrual Cycle: Manifestations and Biopsychosocial Risk Factors. PMC13213724
  2. The role of the neuroinflammation and stressors in premenstrual syndrome/premenstrual dysphoric disorder: a review. PMC11985436
  3. Understanding premenstrual dysphoric disorder from a psychosomatic and a sensory perspective. PMC12319025
Source: the definition and neuroplastic-contribution framing on this page summarise, in our own words, the entry “Premenstrual dysphoric disorder (PMDD)” in the Index of Neuroplastic Symptoms (2026) published by the Association for the Treatment of Neuroplastic Symptoms (ATNS, neuroplastic.org). The research summary cites the PubMed records listed above.
Cindra

A daily companion for the hard days and the ordinary ones.

Cindra is an AI companion from Karuna Labs built around acceptance and commitment therapy and the science of neuroplastic symptoms. It checks in with you each day, helps you notice what your symptoms are pulling you away from, and nudges you back toward the things that matter. Cindra is invite-only while we build it with early members.

Join the waitlist

This article is for general education and is not medical advice, and it does not diagnose or treat any condition. Persistent symptoms deserve a proper medical assessment to rule out disease or injury before a neuroplastic explanation is considered. If your symptoms are new, changing, or come with red-flag signs such as fever, unexplained weight loss, numbness or weakness, chest pain, or loss of bladder or bowel control, see a clinician promptly.